COMPANY PROFILE · UPDATED 18 NOV 2025

Orbital Therapeutics

Orbital Therapeutics aims to enhance global health by unleashing the full potential of RNA-based medicines to treat human disease in ways that were not previously possible.

orbitaltx.com ↗

This profile is unclaimed — do you work here? Claim it

Claim it →

Founded: 2022
Headcount: 64
Open roles: 0
Last raised: Series A · Sign in to view

LEADERSHIP

Founders & key people

Giuseppe Ciaramella

CEO at Orbital Therapeutics

Beam TherapeuticsDewpoint TherapeuticsOrbital TherapeuticsBeamModernaAstraZenecaUniversity College London (UCL)Liceo Scientifico

Drew Weissman

Howard Chang

Ravi Majeti

Gene Yeo

John Maraganore

Carol Suh

COO at Neumora Therapeutics

Orbital TherapeuticsNeumora TherapeuticsArch Venture PartnersHuman Immunology BiosciencesStealth Mode Biotech StartupTrinity PartnersHarvard University

Kristina Burow

OPEN ROLES

Hiring at Orbital Therapeutics

No open roles listed right now. Check back soon or search all jobs →

FUNDING

Capital raised

Total raised

$270,000,000

Investors

Andreessen HorowitzAbu Dhabi Growth Fund (ADG)Agent CapitalAlexandria Venture InvestmentsArch Venture PartnersCasdin CapitalExorHeritage Medical SystemsInvusMoore Strategic VenturesNewpath PartnersRedmile GroupRellim Capital ManagementiGlobe Partners

Funding rounds

Series A
Arch Venture Partners, Casdin Capital, Heritage Medical Systems, Alexandria Venture Investments, Moore Strategic Ventures, iGlobe Partners, Agent Capital, Abu Dhabi Growth Fund (ADG), Newpath Partners, Rellim Capital Management, Exor, Redmile Group, Invus, Andreessen Horowitz
$270MApr 25, 2023